ArticleResearch square2025

BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway.

Amnon Peled et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.